|
1
|
Petersen PE: Oral cancer prevention and
control-the approach of the World Health Organization. Oral Oncol.
45:454–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sarasin A: An overview of the mechanisms
of mutagenesis and carcinogenesis. Mutat Res. 544:99–106. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danaei G, Vander Hoorn S, Lopez AD, Murray
CJ and Ezzati M: Comparative Risk Assessment collaborating group
(Cancers): Causes of cancer in the world: Comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizushima N and Klionsky DJ: Protein
turnover via autophagy: Implications for metabolism. Ann Rev Nutr.
27:19–40. 2007. View Article : Google Scholar
|
|
5
|
Green DR and Levine B: To be or not to be?
How selective autophagy and cell death govern cell fate. Cell.
157:65–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin S: p53, Autophagy and tumor
suppression. Autophagy. 1:171–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenfeldt MT, O'Prey J, Morton JP, Nixon
C, MacKay G, Mrowinska A, Au A, Rai TS, Zheng L, Ridgway R, et al:
p53 status determines the role of autophagy in pancreatic tumour
development. Nature. 504:296–300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong Z, Sanchez-Lopez E and Karin M:
Autophagy, inflammation, and immunity: A troika governing cancer
and its treatment. Cell. 166:288–298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinez-Outschoorn UE, Whitaker-Menezes
D, Lin Z, Flomenberg N, Howell A, Pestell RG, Lisanti MP and Sotgia
F: Cytokine production and inflammation drive autophagy in the
tumor microenvironment: Role of stromal caveolin-1 as a key
regulator. Cell Cycle. 10:1784–1793. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonora M, Wieckowsk MR, Chinopoulos C,
Kepp O, Kroemer G, Galluzzi L and Pinton P: Molecular mechanisms of
cell death: Central implication of ATP synthase in mitochondrial
permeability transition. Oncogene. 34:16082015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kramer IR, Lucas RB, Pindborg JJ and Sobin
LH: Definition of leukoplakia and related lesions: An aid to
studies on oral precancer. Oral Surg Oral Med Oral Pathol.
46:518–539. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vogel U: Overview on techniques to
construct tissue arrays with special emphasis on tissue
microarrays. Microarrays (Basel). 3:103–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pankiv S, Lamark T, Bruun JA, Øvervatn A,
Bjørkøy G and Johansen T: Nucleocytoplasmic shuttling of p62/SQSTM1
and its role in recruitment of nuclear polyubiquitinated proteins
to promyelocytic leukemia bodies. J Biol Chem. 285:5941–5953. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang XH, Scognamiglio T and Gudas LJ:
Basal stem cells contribute to squamous cell carcinomas in the oral
cavity. Carcinogenesis. 34:1158–1164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chu M, Su YX, Wang L, Zhang TH, Liang YJ,
Liang LZ and Liao GQ: Myeloid-derived suppressor cells contribute
to oral cancer progression in 4NQO-treated mice. Oral Dis.
18:67–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao J, Wang Z, Han J, Qiu X, Pan J and
Chen J: Increased frequency of CD4+ CD25+
FOXP3+ cells correlates with the progression of
4-nitroquinoline1-oxide-induced rat tongue carcinogenesis. Clin
Oral Investig. 18:1725–1730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang M, Qiao X, Zhao L, Jiang L and Ren
F: Lactobacillus salivarius REN counteracted unfavorable
4-nitroquinoline-1-oxide-induced changes in colonic microflora of
rats. J Microbiol. 49:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanojia D and Vaidya MM:
4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.
Oral Oncol. 42:655–667. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vitale-Cross L, Czerninski R,
Amornphimoltham P, Patel V, Molinolo AA and Gutkind JS: Chemical
carcinogenesis models for evaluating molecular-targeted prevention
and treatment of oral cancer. Cancer Prev Res (Phila). 2:419–422.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang XH, Osei-Sarfo K, Urvalek AM, Zhang
T, Scognamiglio T and Gudas LJ: Combination of bexarotene and the
retinoid CD1530 reduces murine oral-cavity carcinogenesis induced
by the carcinogen 4-nitroquinoline 1-oxide. Proc Natl Acad Sci USA.
111:8907–8912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen MF, Kuan FC, Yen TC, Lu MS, Lin PY,
Chung YH, Chen WC and Lee KD: IL-6-stimulated CD11b+
CD14+ HLA-DR-myeloid-derived suppressor cells, are
associated with progression and poor prognosis in squamous cell
carcinoma of the esophagus. Oncotarget. 5:8716–8728. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang M, Wang F, Jiang L, Liu R, Zhang L,
Lei X, Li J, Jiang J, Guo H, Fang B, et al: Lactobacillus
salivarius REN inhibits rat oral cancer induced by 4-nitroquioline
1-oxide. Cancer Prev Res. 6:686–694. 2013. View Article : Google Scholar
|
|
25
|
Chen PT, Hsieh CC, Wu CT, Yen TC, Lin PY,
Chen WC and Chen MF: 1α,25-dihydroxyvitamin D3 inhibits esophageal
squamous cell carcinoma progression by reducing IL6 signaling. Mol
Cancer Ther. 14:1365–1375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshioka A: LC3, an autophagosome marker,
is highly expressed in gastrointestinal cancers. Int J Oncol.
33:461–468. 2008.PubMed/NCBI
|
|
28
|
Schmitz KJ, Ademi C, Bertram S, Schmid KW
and Baba HA: Prognostic relevance of autophagy-related markers LC3,
p62/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients
with respect to KRAS mutational status. World J Surg Oncol.
14:1892016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi J, Jung W and Koo JS: Expression of
autophagy-related markers beclin-1, light chain 3A, light chain 3B
and p62 according to the molecular subtype of breast cancer.
Histopathology. 62:275–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu
YC and Hung CH: Prognostic significance of p62/SQSTM1 subcellular
localization and LC3B in oral squamous cell carcinoma. Br J Cancer.
111:944–954. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY
and Chai CY: High LC3 expression correlates with poor survival in
patients with oral squamous cell carcinoma. Hum Pathol.
44:2558–2562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Arozena Acevedo A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iwadate R, Inoue J, Tsuda H, Takano M,
Furuya K, Hirasawa A, Aoki D and Inazawa J: High expression of
SQSTM1/p62 protein is associated with poor prognosis in epithelial
ovarian cancer. Acta Histochem Cytochem. 47:295–301. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakayama S, Karasawa H, Suzuki T, Yabuuchi
S, Takagi K, Aizawa T, Onodera Y, Nakamura Y, Watanabe M, Fujishima
F, et al: p62/sequestosome 1 in human colorectal carcinoma as a
potent prognostic predictor associated with cell proliferation.
Cancer Med. 6:1264–1274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao M, Xu H, Zhang B, Hong B, Yan W and
Zhang J: Impact of nuclear factor erythroid-derived 2-like 2 and
p62/sequestosome expression on prognosis of patients with gliomas.
Hum Pathol. 46:843–849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Umemura A, He F, Taniguchi K, Nakagawa H,
Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S,
Duran A, et al: p62, upregulated during preneoplasia, induces
hepatocellular carcinogenesis by maintaining survival of stressed
HCC-initiating cells. Cancer Cell. 29:935–948. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Valencia T, Kim JY, Abu-Baker S,
Moscat-Pardos J, Ahn CS, Reina-Campos M, Duran A, Castilla EA,
Metallo CM, Diaz-Meco MT and Moscat J: Metabolic reprogramming of
stromal fibroblasts through p62-mTORC1 signaling promotes
inflammation and tumorigenesis. Cancer Cell. 26:121–135. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moscat J and Diaz-Meco MT: p62 at the
crossroads of autophagy, apoptosis, and cancer. Cell.
137:1001–1004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y
and Zheng HC: Aberrant Beclin 1 expression is closely linked to
carcinogenesis, differentiation, progression, and prognosis of
ovarian epithelial carcinoma. Tumour Biol. 35:1955–1964. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park JM, Huang S, Wu TT, Foster NR and
Sinicrope FA: Prognostic impact of Beclin 1, p62/sequestosome 1 and
LC3 protein expression in colon carcinomas from patients receiving
5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther.
14:100–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu Z, Zhong Z, Huang S, Wen H, Chen X, Chu
H, Li Q and Sun C: Decreased expression of Beclin-1 is
significantly associated with a poor prognosis in oral tongue
squamous cell carcinoma. Mol Med Rep. 14:1567–1573. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Romano M, Tung SL, Smyth LA and Lombardi
G: Treg therapy in transplantation: A general overview. Transpl
Int. 30:745–753. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Edozie FC, Nova-Lamperti EA, Povoleri GA,
Scottà C, John S, Lombardi G and Afzali B: Regulatory T-cell
therapy in the induction of transplant tolerance: The issue of
subpopulations. Transplantation. 98:370–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wei J, Long L, Yang K, Guy C, Shrestha S,
Chen Z, Wu C, Vogel P, Neale G, Green DR and Chi H: Autophagy
enforces functional integrity of regulatory T cells by coupling
environmental cues and metabolic homeostasis. Nat Immunol.
17:277–285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang XX, Qiao YC, Li W, Zou X, Chen YL,
Shen J, Liao QY, Zhang QJ, He L and Zhao HL: Human amylin induces
CD4+Foxp3+ regulatory T cells in the
protection from autoimmune diabetes. Immunol Res. 66:179–186. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yin E, Matsuyama S, Uchiyama M, Kawai K
and Niimi M: Graft protective effect and induction of
CD4+Foxp3+ cell by thrombomodulin on
allograft arteriosclerosis in mice. J Cardiothorac Surg. 13:482018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun IH, Oh MH, Zhao L, Patel CH, Arwood
ML, Xu W, Tam AJ, Blosser RL, Wen J and Powell JD: mTOR complex 1
signaling regulates the generation and function of central and
effector Foxp3+ regulatory T cells. J Immunol.
201:481–492. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Oyarce K, Campos-Mora M, Gajardo-Carrasco
T and Pino-Lagos K: Vitamin C fosters the in vivo differentiation
of peripheral CD4+ Foxp3− T cells into
CD4+ Foxp3+ regulatory T cells but impairs
their ability to prolong skin allograft survival. Front Immunol.
9:1122018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Olguin JE, Medina-Andrade I, Molina E,
Vázquez A, Pacheco-Fernández T, Saavedra R, Pérez-Plasencia C,
Chirino YI, Vaca-Paniagua F, Arias-Romero LE, et al: Early and
partial reduction in CD4+Foxp3+ regulatory T
cells during colitis-associated colon cancer induces
CD4+ and CD8+ T cell activation inhibiting
tumorigenesis. J Cancer. 9:239–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
